Compass Therapeutics(CMPX)
Focus: Compass Therapeutics is a Boston-based public biotech focused on antibody therapies and psychedelic-assisted treatments spanning oncology and neurology. The company operates at early clinical stages with a diversified pipeline but minimal commercial revenue.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3
Should You Work at Compass Therapeutics?
AI assessmentCompass is a high-risk, high-upside early-stage play suitable for scientists seeking platform-building roles in novel antibody or psychedelic psychiatry, but not for those prioritizing stability or near-term commercial scale.
Why Work Here
- Early-stage oncology antibody platform (CTX-009, CTX-471, CTX-8371, CTX-10726) with multiple Phase 1/2 trials active, offering deep technical ownership opportunities
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$850K
Pipeline & Clinical Trials
Freedom SCS System
Back PainVideogame
Doping in SportClinical Trials (1)
Help build intelligence for Compass Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.